Redeye - Still masked potential in Mycronic

In the Q2 report released 14th of July, Mycronic showed an unexpectedly strong profitability in Assembly Solutions and the delivery of 3 advanced PG systems exceeded our expectations. Following the report we have updated our short term earnings estimates and the market growth forecasts. Read more and download the Research Update by Viktor Westman at: https://goo.gl/g1ks5R

Become a member at Redeye to access the latest research on Life Science and Tech companies.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/